Rapid identification of Candida spp. in peritonitis patients by Raman spectroscopy

被引:39
作者
Ibelings, MS
Maquelin, K
Endtz, HP
Bruining, HA
Puppels, GJ
机构
[1] Univ Med Ctr Rotterdam, Erasmuc MC, Dept Gen Surg, Ctr Opt Diagnost & Therapy, NL-3015 GD Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmuc MC, Surg Intens Care Unit, NL-3015 GD Rotterdam, Netherlands
[3] Univ Med Ctr Rotterdam, Erasmuc MC, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands
关键词
Candida spp; identification; Raman spectroscopy; rapid identification method; peritonitis; spectroscopy;
D O I
10.1111/j.1469-0691.2005.01103.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This prospective study evaluated Raman spectroscopy for the identification of clinically relevant Candida spp. in peritonitis patients. A Raman database was developed by measuring spectra from 93 reference strains belonging to ten different Candida spp. Clinical samples were obtained from the surgical department and intensive care unit of a tertiary university hospital. In total, 88 peritoneal specimens from 45 patients with primary, secondary or tertiary peritonitis were included. Specimens were cultured initially on a selective Sabouraud medium that contained gentamicin to suppress bacterial growth. For conventional identification, a chromogenic medium was used for presumptive identification, followed by use of the Vitek 2 system for definitive identification (requiring a total time of 48-96 h). Raman measurements were taken on overnight cultures from Sabouraud-gentamicin medium. Thirty-one samples were positive for Candida by culture. Using multivariate statistical analyses, a prediction accuracy of 90% was obtained for Raman spectroscopy, which appears to offer an accurate and rapid (12-24 h) alternative for the identification of Candida spp. in peritonitis patients. The reduced turnaround time is of great clinical importance for the treatment of critically ill patients with invasive candidiasis in intensive care units.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 40 条
[31]   CANDIDA DUBLINIENSIS SP-NOV - PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF A NOVEL SPECIES ASSOCIATED WITH ORAL CANDIDOSIS IN HIV-INFECTED INDIVIDUALS [J].
SULLIVAN, DJ ;
WESTERNENG, TJ ;
HAYNES, KA ;
BENNETT, DE ;
COLEMAN, DC .
MICROBIOLOGY-UK, 1995, 141 :1507-1521
[32]   Rapid differentiation of closely related Candida species and strains by pyrolysis mass spectrometry and Fourier transform-infrared spectroscopy [J].
Timmins, EM ;
Howell, SA ;
Alsberg, BK ;
Noble, WC ;
Goodacre, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (02) :367-374
[33]   Evaluation of phenotypic markers for selection and identification of Candida dubliniensis [J].
Tintelnot, K ;
Haase, G ;
Seibold, M ;
Bergmann, F ;
Staemmler, M ;
Franz, T ;
Naumann, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) :1599-1608
[34]   Development of a hierarchical classification system with artificial neural networks and FT-IR spectra for the identification of bacteria [J].
Udelhoven, T ;
Naumann, D ;
Schmitt, J .
APPLIED SPECTROSCOPY, 2000, 54 (10) :1471-1479
[35]   Comparative study of seven commercial yeast identification systems [J].
Verweij, PE ;
Breuker, IM ;
Rijs, AJMM ;
Meis, JFGM .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (04) :271-273
[36]   THE PREVALENCE OF NOSOCOMIAL INFECTION IN INTENSIVE-CARE UNITS IN EUROPE - RESULTS OF THE EUROPEAN PREVALENCE OF INFECTION IN INTENSIVE-CARE (EPIC) STUDY [J].
VINCENT, JL ;
BIHARI, DJ ;
SUTER, PM ;
BRUINING, HA ;
WHITE, J ;
NICOLASCHANOIN, MH ;
WOLFF, M ;
SPENCER, RC ;
HEMMER, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (08) :639-644
[37]   Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care [J].
Vincent, JL ;
Anaissie, E ;
Bruining, H ;
Demajo, W ;
El-Ebiary, M ;
Haber, J ;
Hiramatsu, Y ;
Nitenberg, G ;
Nystrom, PO ;
Pittet, D ;
Rogers, T ;
Sandven, P ;
Sganga, G ;
Schaller, MD ;
Solomkin, J .
INTENSIVE CARE MEDICINE, 1998, 24 (03) :206-216
[38]  
Warren Ng, 1999, MANUAL CLIN MICROBIO, V7th, P1184
[39]   NOSOCOMIAL CANDIDEMIA - RISK-FACTORS AND ATTRIBUTABLE MORTALITY [J].
WENZEL, RP .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (06) :1531-1534
[40]   HOSPITAL-ACQUIRED CANDIDEMIA - THE ATTRIBUTABLE MORTALITY AND EXCESS LENGTH OF STAY [J].
WEY, SB ;
MORI, M ;
PFALLER, MA ;
WOOLSON, RF ;
WENZEL, RP .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (12) :2642-2645